Brief: Bora Pharmaceuticals Says 2023 Net Profit At T$3.03 Bln
March 7 (Reuters) - Bora Pharmaceuticals Co Ltd
6472.TW :
* SAYS 2023 NET PROFIT AT T$3.03 BILLION ($96.17 million)
Source text for Eikon: ID:nMOP1W8Z4s
Further company coverage: 6472.TW
($1 = 31.5080 Taiwan dollars)
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on BORA PHARMACEUTICALS
See all newsAI shortens drug discovery to around 1 year in China, Insilico CEO says
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine (updated)
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine
Brief: Bora Pharmaceuticals & GSK Sign $250M Five Year Global Manufacturing Contract
Brief: Bora Pharmaceuticals Says Jan-Sept Net Profit T$2.65 Bln